Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
COVID-19 vaccine vaccination myocarditis heart damage inflammation RSNA imaging radiology cardiology

COVID-19 vaccines helped heart failure patients stay out of the hospital and live longer

Vaccination was linked to key benefits in terms of all-cause mortality, heart failure hospitalizations, stroke, heart attack, myocarditis, venous thromboembolism and testing positive for COVID-19. 

Edwards Lifesciences Sapien 3 Ultra Resilia TAVR

Updated balloon-expandable TAVR valve from Edwards outperforming its predecessors

The fifth-generation valve is associated with improved hemodynamic data and a reduced rate of paravalvular leak, according to new research published in JACC: Cardiovascular Interventions and EuroIntervention.

heart patient

New hypertrophic cardiomyopathy guidelines highlight importance of exercise, new drug class

HCM is widely underdiagnosed, but the American College of Cardiology and American Heart Association hope their new guidelines can help cardiologists learn more about the potentially fatal condition and improve patient care. 

the words "FDA recall" on a board

FDA announces new recall of delivery catheters after patient’s death

The recall includes specific lots of five different medical devices used to treat stroke and other neurovascular diseases.

Abbott’s Aveir DR leadless pacemaker, the world’s very first dual-chamber pacing solution of its kind, is associated with a “reliable” performance after six months, according to new data published in Heart Rhythm.[1]

World’s first dual-chamber leadless pacemaker still going strong after 6 months

Abbott’s Aveir DR leadless pacemaker, the first pacing offering of its kind to gain FDA approval, is linked to a consistent electrical performance six months after implant. Researchers tracked data from nearly 400 patients and presented their full findings in Heart Rhythm.

money business cash flow dollar

Medical device company raises $87M to study new-look scaffolds for BTK PAD

R3 Vascular also announced that Christopher M. Owens, a veteran of the medical device industry, is its new president and CEO. 

How beneficial is MR-directed breast ultrasound in reducing biopsies?

A team of experts determined that correlating masses initially detected on MRI are significantly more likely to result in a cancer diagnosis than other common findings. 

HRS 2024: Late-breaking clinical trials will highlight key trends in electrophysiology

A total of 21 late-breaking science presentations are scheduled for Heart Rhythm 2024 in Boston. 

Displaying 577 - 584 of 5932
Design by Adaptive Theme